24-HOUR AND 72-HOUR PRESERVATION OF CANINE KIDNEYS

doi:10.1016/S0140-6736(67)90498-9

The Lancet

Volume 290, Issue 7515, 9 September 1967, Pages 536-539

https://doi.org/10.1016/S0140-6736(67)90498-9 Get rights and content

Abstract

Extracorporeal perfusion of canine kidneys for periods of 24 to 72 hours were consistently successful. The functional viability of the perfused kidneys was proved by reimplanting the perfused kidneys and simultaneously removing the contralateral kidneys. The essential features of successful perfusion are: (1) a pulsatile pump; (2) moderate hypothermia (8-12°C); (3) a buffered perfusate of canine plasma to which are added magnesium sulphate, dextrose, insulin, penicillin, and hydrocortisone; (4) microfiltration of the perfusate before use; (5) oxygenation by means of a membrane oxygenator to limit the air-fluid interphase; and (6) control of pH, temperature, PO₂, PCO₂, and flowrates during perfusion. Since a 24-hour to 72-hour period is adequate for preparing a recipient and such preliminaries as tissue-typing, the details of the technique in twelve consecutive perfusions, six for 24 hours and six for 72 hours are reported.

References (9)

J.R.W. Ackermann et al.
Br. J. Surg.
(1966)
Belzer, F. O., Ashby, B. S....
A.R.C. Dobell et al.
Ann. Surg.
(1965)
A.L. Humphries et al.
Surgery, St. Louis
(1963)

There are more references available in the full text version of this article.

Cited by (385)

Return of the cold: How hypothermic oxygenated machine perfusion is changing liver transplantation
2024, Transplantation Reviews
Hypothermic Oxygenated machine PErfusion (HOPE) has recently emerged as a preservation technique which can reduce ischemic injury and improve clinical outcomes following liver transplantation. First developed with the advent solid organ transplantation techniques, hypothermic machine perfusion largely fell out of favour following the development of preservation solutions which can satisfactorily preserve grafts using the cheap and simple method, static cold storage (SCS). However, with an increasing need to develop techniques to reduce graft injury and better utilise marginal and donation after circulatory death (DCD) grafts, HOPE has emerged as a relatively simple and safe technique to optimise clinical outcomes following liver transplantation. Perfusing the graft with cold, acellular, oxygenated perfusate either via the portal vein (PV) alone, or via both the PV and hepatic artery (HA), HOPE is generally commenced for a period of 1–2 h immediately prior to implantation. The technique has been validated by multiple randomised control trials, and pre-clinical evidence suggests HOPE primarily reduces graft injury by decreasing the accumulation of harmful mitochondrial intermediates, and subsequently, the severity of post-reperfusion injury. HOPE can also facilitate real time graft assessment, most notably via the measurement of flavin mononucleotide (FMN) in the perfusate, allowing transplant teams to make better informed clinical decisions prior to transplantation. HOPE may also provide a platform to administer novel therapeutic agents to ex situ organs without risk of systemic side effects. As such, HOPE is uniquely positioned to revolutionise how liver transplantation is approached and facilitate optimised clinical outcomes for liver transplant recipients.
Normothermic Preservation of the Intestinal Allograft
2024, Gastroenterology Clinics of North America
Nonmechanical preservation and allocation of liver grafts
2023, The Liver Graft Before Transplantation: Defining Outcome After Liver Transplantation
Liver Transplantation: Analysis of Preservation Solutions in the Andalusian Registry
2022, Transplantation Proceedings
The initial objective of this study is to analyze the impact on survival of the preservation solution used. Secondarily, the influence of donor age, underlying pathology, and graft ischemia time is investigated.
A multicenter retrospective analytical observational study has been carried out. A population of 1822 liver transplant recipients is studied in 4 Andalusian hospitals between 1995 and 2014. Survival of the patient and graft is analyzed by groups based on the conservation solution used, the age of the donor, the pathology indicated for transplant and the ischemia time, and the relationship between the variables through a bivariate study. A descriptive and predictive multivariate analysis of the variables was performed.
Comparison of the graft and patient survival functions for each preservation solution did not differ significantly. The bivariate analysis shows a significantly higher utilization of Celsior and histidine-tryptophan-ketoglutarate solution in graft loss. The comparison between donor age groups showed significant differences in favor of donor grafts younger than 50 years. In the multivariate analysis of patient and graft survival, the donor age obtained a hazard ratio of 1.008 (P < .005) with donors older than 47.6 and 47.5 years, respectively.
Survival analysis between pathology groups found significant differences, not obtaining predictive power for patient or graft survival in the multivariate study. No significant differences were found in survival according to ischemia time, but there was a relationship between early graft loss and longer mean cold ischemia times up to 18 hours.
Mitochondria as Therapeutic Targets in Transplantation
2021, Trends in Molecular Medicine
Advances in surgical procedures, technology, and immune suppression have transformed organ transplantation. However, the metabolic changes that occur during organ retrieval, storage, and implantation have been relatively neglected since the developments many decades ago of cold storage organ preservation solutions. In this review we discuss how the metabolic changes that occur within the organ during transplantation, particularly those associated with mitochondria, may contribute to the outcome. We show how a better understanding of these processes can lead to changes in surgical practice and the development of new drug classes to improve the function and longevity of transplanted grafts, while increasing the pool of organs available for transplantation.
The Current Role and Future Applications of Machine Perfusion in Liver Transplantation
2023, Bioengineering

View all citing articles on Scopus

View full text

ORIGINAL ARTICLES24-HOUR AND 72-HOUR PRESERVATION OF CANINE KIDNEYS

Abstract

Br. J. Surg.

Ann. Surg.

Surgery, St. Louis

ORIGINAL ARTICLES
24-HOUR AND 72-HOUR PRESERVATION OF CANINE KIDNEYS